DX & VX CO., LTD.

Highlights Dx & Vx Co., Ltd.

Equities

A180400

KR7180400004

End-of-day quote Korea S.E. Other stock markets 03:30:00 22/05/2024 am IST			5-day change	1st Jan Change
4,050 ^KRW	-1.94%		-9.80%	-31.47%

2023	Dx&Vx Co-Develops Bio-Healthcare Big Data Platform with LG CNS	CI
2023	Dx & Vx Co., Ltd. completed the acquisition of Avixgen, Inc. from a group of sellers	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dx&Vx Co-Develops Bio-Healthcare Big Data Platform with LG CNS	20/12	CI
Dx & Vx Co., Ltd. completed the acquisition of Avixgen, Inc. from a group of sellers	28/23/28	CI
Dx & Vx Co., Ltd. agreed to acquire Avixgen, Inc. from Renaissance Asset Management, Nouveau International Co., Ltd., Lee Mi-ja, Seo Jin - young, Kim Jae-hyun , Cho Il-hyun,Park So -yeon, Jeong Ja -woon, Kim Young- ju, Yang Young-jin, Kim Hye -min and Um In-kyung for KRW 9.2 billion.	24/23/24	CI
Dx & Vx Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	13/23/13	CI
Dx & Vx Co., Ltd. completed the acquisition of Korea Biopharm Co., Ltd. from Jang, Byung Ha, Heo, Won Jung, Kim, Min E, Jang, So Yeon, Kim, Sung Gon and Hyun, Mi Ok.	04/22/04	CI
Dx & Vx Co., Ltd. agreed to acquire Korea Biopharm Co., Ltd. from Jang, Byung Ha, Heo, Won Jung, Kim, Min E, Jang, So Yeon, Kim, Sung Gon and Hyun, Mi Ok for approximately KRW 15 billion.	15/22/15	CI
D S and partners limited company cancelled the acquisition of 10.2% stake in GI Innovation, Inc. from Cancer Rop Co., Ltd..	29/20/29	CI
Cancer Rop Holdings Co., Ltd. cancelled the acquisition of 3.4% stake in Cancer Rop Co., Ltd. from Myungji Global Bio Fund.	11/19/11	CI
Ds&Partners signed a contract to acquire 10.2% stake in GI Innovation, Inc. from Cancer Rop Co., Ltd. for KRW 7.5 billion.	29/19/29	CI
Resort Savers, Inc. Announces Medical Distribution Partnership with South Korea based CancerROP	16/18/16	CI
Cancer Rop Holdings Co., Ltd. singed a contract to acquire 3.4% stake in Cancer Rop Co., Ltd. from Myungji Global Bio Fund for approximately KRW 9.5 billion.	11/18/11	CI
Wangjun Lee completed the acquisition of 25.8% stake in MG MED, Inc. (KOSDAQ:A 180400) from Macrogen Inc..	12/17/12	CI
Myungji Global Bio Fund and Blue Win AMC Co., Ltd. signed a share acquisition contract to acquire 25.8% stake in MG MED, Inc. from Macrogen Inc. for KRW 22.6 billion.	30/17/30	CI
Platform Partners Asset Management Co., Ltd. acquired 11.18% stake in MG MED, Inc..	16/16/16	CI
MG MED, Inc. has completed an IPO in the amount of KRW 14.00 billion.	12/15/12	CI
MG MED, Inc. has filed an IPO.	31/15/31	CI
SBI-growth Growth Ladder KONEX Vitalization Fund managed by SBI-growth Growth Ladder KONEX Vitalization Fund acquired 4.17% stake in MG MED, Inc. from Psoma Therapeutics, Inc. for KRW 1.8 billion.	03/15/03	CI
Smilegate Youth Start-up Fund managed by Smilegate Youth Start-up Fund acquired 3.33% stake in MG MED, Inc. from Psoma Therapeutics, Inc. for KRW 1.4 billion.	03/15/03	CI
KB12-1 Venture Fund managed by KB Investment Co., Ltd. acquired 4.17% stake in MG MED, Inc. from Psoma Therapeutics, Inc. for KRW 1.8 billion.	03/15/03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer